Table 3.
Clinical inquiries from DR-TB treatment sites and recommendations of the consilium
| Count (%) | |
|---|---|
| Clinical inquiries from DR-TB sites (N = 308) | |
| Construction of treatment regimen | 119 (38.6) |
| Management of adverse effect | 74 (24.0) |
| Determination treatment duration | 67 (21.8) |
| Validation of already prescribed regimen | 30 (9.7) |
| Establishment of DR-TB diagnosis | 17 (5.5) |
| Unknown | 1 (0.3) |
| Recommendations of consilium (N = 471) | |
| Construction of initial DR-TB regimen | 102 (21.7) |
| Observation while on current regimen | 78 (16.6) |
| Adherence counselling | 66 (14.0) |
| Dose adjustment | 36 (7.6) |
| Further diagnostic work up | 35 (7.4) |
| Further clinical evaluation by specialist | 32 (6.8) |
| Substitution of single agent in the regimen | 30 (6.4) |
| Change of regimen (substituting 2 or more agents) | 25 (5.3) |
| Adjunct medication | 23 (4.9) |
| Withholding a single agent without substituting it | 15 (3.2) |
| Withholding all DR-TB treatment for a while | 13 (2.8) |
| Other recommendation | 16 (3.4) |
DR-TB–drug resistant tuberculosis